Is Bal Pharma Limited stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Bal Pharma Limited pays dividends. Last time was Friday 25th of October 2024 where the investors holding the stock on Wednesday 18th of September 2024 were paid INR1.2 per share. Over the last 15 times between 2006 and 2024, Bal Pharma Limited has paid INR14.2 with an average of INR0.95 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Bal Pharma Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR40.05, you would have made a profit of INR93.58 per share or 233.66%
Yes, the average daily trading liquidity for Bal Pharma Limited is INR128 484 thousand. You should therefore be able to get in and out of your positions relatively fast.
Bal Pharma Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.14, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 2.51%, which is challenging.
We have calculated the inflation risk for Bal Pharma Limited to be low [0.5 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.